PROPYLAMYLATIN

Class [005]
Pharmaceutical Products

veterinary preparations for the treatment of bacterial infections, viral infections, fungal infections, protozoal diseases, and parasite conditions; pharmaceutical preparations for treatment of bacterial infections, viral infections, fungal infections, protozoal diseases, and parasite conditions; anti-parasitic pharmaceutical preparations; anti-parasitic preparations for veterinary use; veterinary preparations, namely, anti-parasitic products for veterinary use; pharmaceutical products and preparations for the prevention and treatment of infectious or parasitic diseases; anti-protozoal pharmaceutical preparations; anti-protozoal pharmaceutical agents for veterinary use; anti-bacterial pharmaceutical preparations; anti-bacterial pharmaceuticals for veterinary use; anti-viral pharmaceutical preparations; anti-viral pharmaceuticals for veterinary use; anti-fungal pharmaceuticals; anti-fungal pharmaceuticals for veterinary use; anti-protozoal pharmaceuticals; anti-protozoal pharmaceuticals for veterinary use; anti-infective pharmaceutical preparations; anti-infective pharmaceutical preparations for veterinary use; anti-microbial pharmaceutical preparations; anti-microbial pharmaceutical preparations for veterinary use; pharmaceutical preparations for treatment and prevention of infectious diseases; veterinary preparations for treatment and prevention of infectious diseases; antimicrobial preparations and substances for the prevention, inhibition, treatment, and disinfection of bacterial, fungal, and other microbial infections, microbial conditions, and microbial growth in or near humans and animals and their environs, including maintaining hygiene in and on surfaces and materials for preparation of food and beverages, waste accumulation and disposal, and in living and work spaces; pharmaceutical preparations for the inhibition of bacterial, fungal and microbial activity, and for the prevention and treatment of bacterial, fungal and microbial infections in humans and animals; anti-fungal preparations for medical use; pharmaceutical preparations and substances for the treatment of viral and respiratory related diseases and disorders; pharmaceutical preparations for the treatment or prevention of disorders or diseases caused by bacteria; probiotic supplement formulations for veterinary use, namely, antibacterial treatments, microbiome modulating treatments, anti-infective treatments and prophylaxis; veterinary preparations active in the microbiome space, namely, probiotic and prebiotic supplements; veterinary preparations for providing antibodies for the protection against disease; preparations for destroying parasites